GET TO KNOW DAXXIFY

We are excited to present DAXXIFY

The only long-lasting, peptide-powered treatment for frown lines. As one of the first exclusive providers of this groundbreaking solution, we invite you to contact our office or schedule online to book your initial appointment.

What makes DAXXIFY different?

Daxxify is FDA approved to help reduce and smooth moderate to severe lines between the brows going after those pesky 11s. Additionally, it can smooth and reduce fine lines around the eyes and forehead. We might even select it for our popular lip flip. This treatment is the only long-lasting option for frown lines that is powered by a peptide, delivering results that typically last between 6 to 9 months for some patients.

In contrast, conventional injectables last only 3 to 4 months and may require up to four treatments per year to maintain effects.

Almost 90% of patients expressed a desire for longer lasting results with their favorite toxin. With Daxxify, you can achieve a smoother appearance for up to a year with just 2 to 3 treatments.

Why are peptides important?

All frown line treatments require a special protein ingredient to stabilize botulinum toxin A to help smooth moderate to severe fine-lines and wrinkles.

Most traditional frown line treatments include specific stabilizing ingredients to enhance their efficacy. For example, Botox cosmetic utilizes human serum albumin (HSA), a blood-derived product to stabilize its formulation. Well, Dysport employs both HSA and cow milk protein as protectants.

What sets Daxxify a part is its unique formulation, which uses a novel peptide as a stabilizer, eliminating the need for human or animal byproducts. This innovation not only enhances the safety profile, but also contributes to a more effective and sustainable approach in frown line treatments. By harnessing the power of peptides, Daxxify can provide patients with a product that is both effective and free from traditional biological components, ensuring a smoother and more natural appearance with reduce risks of adverse reactions. This advancement formulation highlights the importance of peptides in delivering safe and effective toxin treatments.